Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
OBrien, Terence
NCT04938427 / 2021-002481-40: A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome	Completed	3	270	Europe, Canada, Japan, US, RoW	Soticlestat, TAK-935, Placebo	Takeda	Lennox Gastaut Syndrome (LGS)	01/24	01/24
NCT04940624 / 2021-002480-22: A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome	Completed	3	144	Europe, Canada, Japan, US, RoW	Soticlestat, TAK-935, Placebo	Takeda	Dravet Syndrome (DS)	04/24	04/24
ENDYMION 2, NCT05163314 / 2021-002482-17: A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome	Recruiting	3	400	Europe, Canada, Japan, US, RoW	Soticlestat, TAK-935	Takeda	Dravet Syndrome (DS), Lennox Gastaut Syndrome (LGS)	05/26	05/26
NCT04244175: A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures	Active, not recruiting	2	154	Europe, US, RoW	CVL-865, Placebo	Cerevel Therapeutics, LLC	Seizures	05/24	07/24
Ferri, Meritxell Martinez
NCT04244175: A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures	Active, not recruiting	2	154	Europe, US, RoW	CVL-865, Placebo	Cerevel Therapeutics, LLC	Seizures	05/24	07/24